igf 1 lr3 1 mg dosage IGF-1 1MG Recombinant Human LR3 IGF-I/IGF-1 GMP

Embodiment 50 The antibody according to any one of embodiments 1-8, wherein said antibody comprises at least one heavy chain variable region (VH) and at least one light chain variable region (VL), wherein said light chain variable region is a light chain variable region of an antibody selected from the group consisting of M25ADLF, Embodiment 51 The antibody of embodiment 50, wherein said antibody contains at least one light chain variable region of an M25ADLF antibody

For personalized advice, consult your healthcare provider immediately after an injection and avoid strenuous exercise

Sanbe T, Tomofuji T, Ekuni D, Azuma T, Tamaki N, Yamamoto T

All the 3D protein structures were prepared using the Protein Preparation Wizard of Schrodinger, while docking of taxol was performed using LiGen [15] in each binding site